Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-08-02 Sale | 2022-08-04 6:24 pm | Nabriva Therapeutics plc | NBRV | BURGESS DANIEL D Director | 11,341 | $0.1901 | $2,156 | 10,384 (Direct) | View |
| 2022-08-02 Sale | 2022-08-04 6:22 pm | Nabriva Therapeutics plc | NBRV | Broom Colin MD Director | 5,339 | $0.1902 | $1,015 | 36,523 (Direct) | View |
| 2022-08-02 Sale | 2022-08-04 6:20 pm | Nabriva Therapeutics plc | NBRV | Webster Stephen W Director | 7,826 | $0.19 | $1,487 | 11,447 (Direct) | View |
| 2022-08-02 Sale | 2022-08-04 6:19 pm | Nabriva Therapeutics plc | NBRV | CORRIGAN MARK Director | 10,297 | $0.19 | $1,956 | 7,203 (Direct) | View |
| 2022-08-01 Sale | 2022-08-03 9:48 pm | Nabriva Therapeutics plc | NBRV | Rowland Charles A Jr Director | 8,496 | $0.175 | $1,487 | 15,277 (Direct) | View |
| 2022-08-01 Sale | 2022-08-03 9:47 pm | Nabriva Therapeutics plc | NBRV | Bourdow Carrie L. Director | 8,540 | $0.1741 | $1,487 | 9,933 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-01-29 Tax Withholding | 2023-01-31 8:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. Director | 140 | $1.5 | 14,283 (Direct) | View |
| 2023-01-29 Tax Withholding | 2023-01-31 8:55 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Director | 431 | $1.5 | 11,989 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-10 5:58 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 5 | $1.3 | 14,423 (Direct) | View |
| 2023-01-06 Tax Withholding | 2023-01-10 5:56 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 11 | $1.3 | 12,420 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 6:09 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 5 | $1.89 | 12,431 (Direct) | View |
| 2022-12-31 Tax Withholding | 2023-01-04 6:08 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 3 | $1.89 | 14,428 (Direct) | View |
| 2022-12-06 Tax Withholding | 2022-12-08 4:37 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 4 | $2.02 | 14,431 (Direct) | View |
| 2022-12-06 Tax Withholding | 2022-12-08 4:34 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 9 | $2.02 | 12,436 (Direct) | View |
| 2022-11-30 Tax Withholding | 2022-12-02 5:17 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 3 | $2.25 | 14,435 (Direct) | View |
| 2022-11-30 Tax Withholding | 2022-12-02 5:15 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 5 | $2.25 | 12,445 (Direct) | View |
| 2022-11-06 Tax Withholding | 2022-11-08 5:26 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 4 | $2.2392 | 14,438 (Direct) | View |
| 2022-11-06 Tax Withholding | 2022-11-08 5:24 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 10 | $2.2392 | 12,450 (Direct) | View |
| 2022-10-31 Tax Withholding | 2022-11-01 5:08 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 5 | $2.54 | 12,460 (Direct) | View |
| 2022-10-31 Tax Withholding | 2022-11-01 5:06 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 3 | $2.54 | 14,442 (Direct) | View |
| 2022-10-06 Tax Withholding | 2022-10-11 5:03 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 9 | $2.72 | 12,465 (Direct) | View |
| 2022-10-06 Tax Withholding | 2022-10-11 5:00 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 4 | $2.72 | 14,445 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 9:36 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 3 | $2.08 | 14,449 (Direct) | View |
| 2022-09-30 Tax Withholding | 2022-10-04 9:31 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 5 | $2.08 | 12,474 (Direct) | View |
| 2022-09-06 Tax Withholding | 2022-09-07 6:00 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 225 | $0.1566 | 311,977 (Direct) | View |
| 2022-09-06 Tax Withholding | 2022-09-07 5:57 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 89 | $0.1566 | 361,311 (Direct) | View |
| 2022-08-31 Tax Withholding | 2022-09-01 6:38 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 107 | $0.1646 | 312,202 (Direct) | View |
| 2022-08-31 Tax Withholding | 2022-09-01 6:35 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 61 | $0.1646 | 361,400 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 8:50 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 719,400 | $0 | 359,700 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 8:43 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 280,200 | $0 | 140,100 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 8:39 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Naftzger J. Christopher General Counsel and Corp Sec | 189,600 | $0 | 94,800 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 8:39 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Dolan Daniel Chief Financial Officer | 249,600 | $0 | 124,800 (Direct) | View |
| 2022-08-11 Exercise | 2022-08-15 8:34 pm | N/A 2032-01-27 | Nabriva Therapeutics plc | NBRV | Guico-Pabia Christine J. Chief Medical Officer | 214,400 | $0 | 107,200 (Direct) | View |
| 2022-08-06 Tax Withholding | 2022-08-08 5:45 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 89 | $0.1847 | 361,461 (Direct) | View |
| 2022-08-06 Tax Withholding | 2022-08-08 5:44 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 225 | $0.1847 | 312,309 (Direct) | View |
| 2022-07-31 Tax Withholding | 2022-08-03 9:46 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Dalton Lisa Director | 8,400 | $0.179 | 9,100 (Direct) | View |
| 2022-07-31 Tax Withholding | 2022-08-03 9:45 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Schroeder Theodore R Chief Executive Officer | 107 | $0.179 | 312,534 (Direct) | View |
| 2022-07-31 Tax Withholding | 2022-08-03 9:43 pm | N/A N/A | Nabriva Therapeutics plc | NBRV | Gelone Steven P. President and COO | 61 | $0.179 | 361,550 (Direct) | View |